Clinical evidence requirements according to the IVDR 2017/746: practical tools and references for underpinning clinical evidence of IVD-MDs
Open Access
- 26 January 2023
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 61 (7) , 1150-1157
Abstract
In May 2022, the European Regulation 2017/746 (IVDR) came into force. It changes the approach of in vitro medical devices (IVD-MDs) for industry and institutions. It reinforces the clinical evidence requirements to improve performance, safety and transparency. Despite extended transition periods and existing guides, IVDR remains difficult to interpret and bringing devices into compliance requires efforts. The generation of clinical evidence is essential to demonstrate compliance with IVDR, and encompasses scientific validity, analytical performance and clinical performance. It is required to demonstrate, per intended use in the target population and clinical care pathway, IVD-MDs clinical performance (compared to a predefined clinical performance). Thus, there is a need for IVD-manufacturers and end-users in health care institutions, to obtain guidance on how to generate this clinical evidence. This article aims industrials and clinicians to identify key steps imposed by the IVDR for bringing IVD-MDs to the EU-market. We propose a general view of performance evaluation requirements for IVD-MDs and provide key references, including how to establish study design that will enable to document clinical performance of existing, refined or emerging medical tests. Finally, we propose a roadmap to address the relevant questions and studies in relation to the documents requested in the IVDR.Keywords
This publication has 20 references indexed in Scilit:
- Setting clinical performance specifications to develop and evaluate biomarkers for clinical useAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2019
- How to: evaluate a diagnostic testClinical Microbiology and Infection, 2019
- A Universal Standard for the Validation of Blood Pressure Measuring DevicesHypertension, 2018
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsBMJ, 2016
- Sample size estimation in diagnostic test studies of biomedical informaticsJournal of Biomedical Informatics, 2014
- From biomarkers to medical tests: The changing landscape of test evaluationClinica Chimica Acta, 2014
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- What Is Clinical Utility and Why Should We Care?Clinical Pharmacology & Therapeutics, 2010
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960